CoronaVIR: A Web-Based Platform on Coronavirus Disease-19 to Maintain Predicted Diagnostic, Drug, and Vaccine Candidates

CoronaVIR is a comprehensive, multi-modular web resource developed to maintain both predicted and existing scientific information on SARS-CoV-2. This platform serves as a holistic toolkit for the scientific community, integrating genomic analysis, diagnostic tool development, and the discovery of therapeutic and vaccine candidates to combat the COVID-19 pandemic. Web Server: https://webs.iiitd.edu.in/raghava/coronavir/ Citation Patiyal, S., Kaur, D., Kaur, H., Sharma, N., Dhall, A., Sahai, S., Agrawal, P., Maryam, L., Arora, C., & Raghava, G. P. S. (2020). A Web-Based Platform on Coronavirus Disease-19 to Maintain Predicted Diagnostic, Drug, and Vaccine Candidates. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, 39(5), 154-161. https://doi.org/10.1089/mab.2020.0035 About the Platform CoronaVIR was established to consolidate rapidly evolving data on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It employs state-of-the-art in silico techniques to provide high-confidence predictions for diagnostics and therapeutics, ensuring that researchers have access to the latest computational insights. Holistic Approach: Integrates four major modules: Genomics, Diagnosis, Immunotherapy, and Drug Designing. Universal Coverage: Focuses on identifying candidates (like primers and epitopes) that are effective across all known strains of the virus.